Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype.
Saved in:
| Title: | Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype. |
|---|---|
| Authors: | Kreps LM; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Yakubovich E; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Zhao H; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada., Yimer S; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Translational and Molecular Medicine Program, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Yang E; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada., Cruz J; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Translational and Molecular Medicine Program, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Vanderhyden B; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada., Addison CL; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada. |
| Source: | Journal of bone oncology [J Bone Oncol] 2026 Feb 21; Vol. 57, pp. 100754. Date of Electronic Publication: 2026 Feb 21 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101610292 Publication Model: eCollection Cited Medium: Print ISSN: 2212-1366 (Print) Linking ISSN: 22121366 NLM ISO Abbreviation: J Bone Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41777792 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kreps+LM%22">Kreps LM</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yakubovich+E%22">Yakubovich E</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yimer+S%22">Yimer S</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Translational and Molecular Medicine Program, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yang+E%22">Yang E</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Cruz+J%22">Cruz J</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Translational and Molecular Medicine Program, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Vanderhyden+B%22">Vanderhyden B</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Addison+CL%22">Addison CL</searchLink>; Cancer Research Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, Ontario, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101610292%22">Journal of bone oncology</searchLink> [J Bone Oncol] 2026 Feb 21; Vol. 57, pp. 100754. <i>Date of Electronic Publication: </i>2026 Feb 21 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101610292 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2212-1366 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222121366%22">22121366 </searchLink><i>NLM ISO Abbreviation: </i>J Bone Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41777792 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jbo.2026.100754 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100754 Titles: – TitleFull: Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kreps LM – PersonEntity: Name: NameFull: Yakubovich E – PersonEntity: Name: NameFull: Zhao H – PersonEntity: Name: NameFull: Yimer S – PersonEntity: Name: NameFull: Yang E – PersonEntity: Name: NameFull: Cruz J – PersonEntity: Name: NameFull: Vanderhyden B – PersonEntity: Name: NameFull: Addison CL IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 02 Text: 2026 Feb 21 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2212-1366 Numbering: – Type: volume Value: 57 Titles: – TitleFull: Journal of bone oncology Type: main |
| ResultId | 1 |